Jürgen Volz

Title: Jürgen Volz: Innovator in Pharmaceutical Chemistry

Introduction

Jürgen Volz is a notable inventor based in Radolfzell, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of three patents to his name, Volz's work has the potential to impact the treatment of various medical conditions.

Latest Patents

One of Volz's latest patents is focused on pyrazolone derivatives as PDE4 inhibitors. The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is recognized as an effective inhibitor of type 4 phosphodiesterase. This compound shows promise in the treatment of psoriasis and atopic dermatitis. Another significant patent involves (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts. This patent covers a salt of the compound selected from various groups, including hydrobromide and benzenesulfonate.

Career Highlights

Throughout his career, Jürgen Volz has worked with prominent companies in the pharmaceutical industry. Notable among these are 4SC AG and Takeda GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Volz has collaborated with several professionals in his field, including Martin Feth and Rolf-Peter Hummel. These collaborations have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Jürgen Volz is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to advancing medical treatments, particularly for skin conditions. The impact of his contributions continues to be felt in the industry.